InsidersTradesSigma
Track the CStone Pharmaceuticals - B share price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Operating in the Health Care sector, CStone Pharmaceuticals - B has published 21 insider filings. Market capitalisation: €7.4bn. The latest transaction was filed on 7 July 2026 (Other). Among the most active insiders: Yang Jianxin. Every trade is accessible without an account.
21
Insider Decl.
n/a
Thresholds
€1m
14 ops.
Buy Volume
n/a
n/a
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,713 of 28,753 companies
18.5
score / 100
Value24
Quality13
FCF yld-3.8%
Earn yld-5.0%
EV/EBITDA·
ROE-89%
Gross mgn19%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 July 2026
Declarations21 total
63,000 sharesShareXHKGHKEX:DA20260707E00463
448,875 sharesShareXHKGHKEX:DA20260701E00108
331,000 shares@ HK$4.64230.018% mcap30.2% of flowShareXHKGHKEX:DA20260701E00109
11,270,000 sharesShareXHKGHKEX:DA20260625E00306
56,500 shares@ HK$4.660.0004% mcap7.3% of flowShareXHKGHKEX:DA20260615E00264
200,000 shares@ HK$4.570.0014% mcap25.4% of flowShareXHKGHKEX:DA20260612E00338
400,000 shares@ HK$4.47890.0027% mcap100.0% of flowShareXHKGHKEX:DA20260610E00351
145,000 shares@ HK$4.25930.0009% mcap17.2% of flowShareXHKGHKEX:DA20260610E00353
200,000 shares@ HK$4.2550.0013% mcap47.4% of flowShareXHKGHKEX:DA20260609E00345
200,000 shares@ HK$4.7550.0014% mcap52.6% of flowShareXHKGHKEX:DA20260605E00376
105,000 shares@ HK$4.87760.0059% mcap9.0% of flowShareXHKGHKEX:DA20260603E00307
21 of 21 declarations
About CStone Pharmaceuticals - B
CStone Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for cancer. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.